Shaping EU medicines regulation in the post COVID-19 era

por Cavaleri, Marco, Sweeney, Fergus, Gonzalez-Quevedo, Rosa, Carr, Melanie
Publicado 2021

Big Data – How to Realize the Promise

por Cave, Alison, Brun, Nikolai C., Sweeney, Fergus, Rasi, Guido, Senderovitz, Thomas
Publicado 2020

COVID-19 kick-starts a new era for clinical trials and pandemic preparedness in Europe

por Szepessy, Edit, Arlett, Peter, Sweeney, Fergus, Broich, Karl, Rys, Andrzej Jan
Publicado 2022

Navigating stormy waters: 10 years of operation of the European Union Regulatory Network Incident Management Plan for Medicines for Human Use

por Santoro, Aniello, Caplanusi, Irina, Sweeney, Fergus, Cappelli, Benedicte, Nolan, Lorraine, Straus, Sabine, Arlett, Peter
Publicado 2020

Clinical Trials for COVID‐19: Can we Better Use the Short Window of Opportunity?

por Eichler, Hans‐Georg, Cavaleri, Marco, Enzmann, Harald, Scotti, Francesca, Sepodes, Bruno, Sweeney, Fergus, Vamvakas, Spiros, Rasi, Guido
Publicado 2020

Enhancing clinical evidence by proactively building quality into clinical trials

por Meeker-O’Connell, Ann, Glessner, Coleen, Behm, Mark, Mulinde, Jean, Roach, Nancy, Sweeney, Fergus, Tenaerts, Pamela, Landray, Martin J
Publicado 2016